ITCI - Intra-Cellular Therapies Inc. (ITCI) Q1 2024 Earnings Call Transcript
2024-05-07 13:47:10 ET
Intra-Cellular Therapies, Inc. (ITCI)
Q1 2024 Earnings Conference Call
May 07, 2024, 8:30 AM ET
Company Participants
Juan Sanchez - Vice President of Corporate Communications and Investor Relations
Sharon Mates - Founder, Chairman and Chief Executive Officer
Mark Neumann - Executive Vice President and Chief Commercial Officer
Lawrence Hineline - Senior Vice President of Finance and Chief Financial Officer
Suresh Durgam - Executive Vice President and Chief Medical Officer
Conference Call Participants
Jessica Fye - JPMorgan
Brian Abrahams - RBC Capital Markets
Andrew Tsai - Jefferies
Charles Duncan - Cantor Fitzgerald
Marc Goodman - Leerink Partners
Michael DiFiore - Evercore ISI
Jason Gerberry - Bank of America Securities
Sumant Kulkarni - Canaccord Genuity
Michael Riad - Morgan Stanley
Charles Wang - Mizuho Securities
Troy Langford - TD Cowen
Ashwani Verma - UBS
Ami Fadia - Needham
Corinne Johnson - Goldman Sachs
David Amsellem - Piper Sandler
Joel Beatty - Baird
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies' First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would like now to turn the conference over to your speaker today Dr. Juan Sanchez, Vice President, Corporate Communication and Investor Relations. Please go ahead.
Juan Sanchez
Good morning and thank you all for joining us on our first quarter 2024 earnings call. Joining me today on the call are Dr. Sharon Mates, Chairman and Chief Executive Officer; Mark Neumann, Chief Commercial Officer; Dr. Suresh Durgam, Chief Medical Officer; and Larry Hineline, Chief Financial Officer.
The slides to help guide today's call are available under the Investor Events section of our corporate website. I'm on slide number two. During today's call, we will be making certain forward-looking statements. These forward-looking statements are based on current information, assumptions and expectations. Those statements are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements....
Intra-Cellular Therapies, Inc. (ITCI) Q1 2024 Earnings Call Transcript